AzeRx LLC (AKA: Arizona Engineered Therapeutics Inc) Profile last edited on: 6/12/19
CAGE: 47QB5
UEI:
Business Identifier: Peptide-based therapeutic to enhance stent/graft patency Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
3863 West Park Avenue
Chandler, AZ 85226
Chandler, AZ 85226
(602) 300-1649 |
N/A |
N/A |
Location: Single
Congr. District: 09
County: Maricopa
Congr. District: 09
County: Maricopa
Public Profile
In February 2006, AzeRx was acquired by OrthoLogic (NASDAQ OLGC) - another Arizona firm being also SBIR involved in its own right. AzERx Inc., was created with the assistance of the Arizona Technology Enterprises, ASU's technology venturing company. AzeRx came out of Arizona State University to exploit the commercial applications of the principal's research findings that the imitator of the natural protein HSP20 causes relaxation in the same way as the natural protein. Researchers have developed a technique to aid coronary bypasses. They are focused to the development of a drug that promotes blood vessel relaxation. Severe spasm of blood vessels contributes to the failure of coronary bypass surgeries and to strokes following the rupture of an aneurysm in the brain.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
YesPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2006 | 2 | NIH | $1,094,965 | |
Project Title: Development of a vasoactive biogel | ||||
0 | 1 | NIH | $95,000 | |
Project Title: Development of a vasoactive biogel |
Key People / Management
Colleen M Brophy -- President
Company News
There are no news available.